Publication:
The type I collagen induction of MT1-MMP-mediated MMP-2 activation is repressed by αVβ3 integrin in human breast cancer cells

dc.contributor.authorKulrut Borrirukwaniten_US
dc.contributor.authorMarc A. Lafleuren_US
dc.contributor.authorFrancesca A. Mercurien_US
dc.contributor.authorTony Blicken_US
dc.contributor.authorJohn T. Priceen_US
dc.contributor.authorRafael Fridmanen_US
dc.contributor.authorJoseph J. Pereiraen_US
dc.contributor.authorVijittra Leardkamonkarnen_US
dc.contributor.authorErik W. Thompsonen_US
dc.contributor.otherUniversity of Melbourneen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherSt Vincent's Instituteen_US
dc.contributor.otherWayne State Universityen_US
dc.date.accessioned2018-08-24T01:42:14Z
dc.date.available2018-08-24T01:42:14Z
dc.date.issued2007-05-01en_US
dc.description.abstractThe influence of αVβ3 integrin on MT1-MMP functionality was studied in human breast cancer cells of differing β3 integrin status. Overexpression of β3 integrin caused increased cell surface expression of αV integrin and increased cellular adhesion to extracellular matrix (ECM) substrates in BT-549, MDA-MB-231 and MCF-7 cells. β3 integrin expression also enhanced the migration of breast cancer cells on ECM substrates and enhanced collagen gel contraction. In vivo, αVβ3 cooperated with MT1-MMP to increase the growth of MCF-7 cells after orthotopic inoculation in immunocompromised mice, but had no influence on in vitro proliferation. Despite these stimulatory effects, overexpression of β3 integrin suppressed the type I collagen (Col I) induced MMP-2 activation in all breast cancer cell lines analyzed. This was also evident in extracts from the MCF-7 tumors in vivo, where MMP-2 activation was stimulated by MT1-MMP transfection, but attenuated with β3 integrin expression. Although our studies confirm important biological effects of αVβ3 integrin on enhancing cell adhesion and migration, ECM remodeling and tumor growth, β3 integrin caused reduced MMP-2 activation in response to Col I in vitro, which appears to be physiologically relevant, as it was also seen in tumor xenografts in vivo. The reduction of MMP-2 activation (and thus MT1-MMP activity) by αVβ3 in response to Col I may be important in scenarios where cells which are activated for matrix degradation need to preserve some pericellular collagen, perhaps as a substrate for cell adhesion and migration, thus maintaining a balanced level of proteolysis required for efficient tumor growth. © 2006.en_US
dc.identifier.citationMatrix Biology. Vol.26, No.4 (2007), 291-305en_US
dc.identifier.doi10.1016/j.matbio.2006.10.014en_US
dc.identifier.issn0945053Xen_US
dc.identifier.other2-s2.0-34247538440en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/24203
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=34247538440&origin=inwarden_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.titleThe type I collagen induction of MT1-MMP-mediated MMP-2 activation is repressed by αVβ3 integrin in human breast cancer cellsen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=34247538440&origin=inwarden_US

Files

Collections